Background: Group A Streptococcus (GAS) is an important cause of morbidity and mortality among children and responsible for 20-30% of bacterial pharyngitis.
Introduction
Group A Streptococcus (GAS) is a Gram positive spherical bacterium that causes different spectrum of human infections, ranging from pharyngitis and pyoderma, to life threatening immunological complications such as acute rheumatic fever (ARF), rheumatic heart disease (RHD), post streptococcal glomerulonephritis (PSGN), toxic shock syndrome (TSS) and necrotizing fasciitis. 1, 2 Globally, it is estimated that about 600 million cases of symptomatic GAS pharyngitis occur annually among people aged over 4 years and over 550 million of these occur in less developed countries. The greatest global burden of GAS disease is due to RHD which follows GAS pharyngitis, where 15 million cases and 349,000 deaths occur worldwide annually. Ninety-five percent of the disease burden from RHD is in low and middle income countries where it continues to have a significant impact on the health of children and young adults. There are 2.4 million affected children between 5 and 14 years of age in developing countries, 1 million of whom live in Sub-Saharan Africa, making the continent the major ARF=RHD hotspot. [3] [4] [5] Ethiopia as one of the African countries shares the burden of ARF. Accordingly, 50-64% of heart disease among children was reported to be of rheumatic origin. 6 Similarly, the rate of RHD among cardiac admission in Ethio-Swedish Children's Hospital was 54.5%. 7 It is also documented that the prevalence of RHD among Ethiopian cardiac patients in Addis Ababa city and Jimma town was 39.6% and 32.8%, respectively. 8, 9 Despite the high burden of GAS pharyngitis and its severe immunological sequelae, much is not done on epidemiology, antimicrobial susceptibility pattern and clinical information regarding the disease. Therefore, the aim of this study was to determine the prevalence, antimicrobial susceptibility pattern and clinical predictors of GAS among children with pharyngitis.
Materials and methods

Study participants
A cross sectional study was conducted on 355 children aged 5-15 years with pharyngitis presenting at two Health Centers in Jimma town from May to December 2013. Children who were on antibiotic treatment or who had taken antibiotics within 7 days before sample collection were excluded from the study.
Patients' demographic and clinical information were collected using a structured questionnaire by trained health officers.
Collection, transportation and processing of throat swab
Trained health officers collected the throat samples from posterior pharynx and tonsils using sterile cotton swabs. Necessary care was taken not to swab the cheeks, tongues, lips or other areas of the mouth. The swabs were placed immediately in Amies transport medium (Oxoid, England) and transported to Jimma University Microbiology Laboratory and processed within 2 hours of collection. 10, 11 Then, the throat swabs were inoculated onto 5% sheep's blood agar plates and incubated for 24 h at 37°C in a candle jar, which can provide an atmosphere of 5% CO 2 . Culture plates negative for b-haemolytic colonies were incubated for additional 24 hours to allow the growth of slow growers. Identification of GAS isolates was made based on the standard microbiological techniques which include b-haemolytic activity on sheep's blood agar, small colony characteristics, Gram positive cocci , catalase production negative, 0.04-U bacitracin disc susceptibe and PYR positive (Hardy Diagnostics, USA) tests. 10, 12 
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was done by using the disc diffusion method according to criteria set by Clinical Laboratory and Standard Institute (CLSI) and European Committee of Antimicrobial Susceptibility Testing (EUCAST). The pure colony of GAS bacterial suspension from brain heart infusion broth (BHI) was evenly spread onto Muller Hinton agar supplemented with 5% sheep blood using sterile cotton swab. Soon after, antibiotic discs were placed on the inoculated plate and the plates were incubated at 37°C in a candle jar overnight. The following antimicrobial discs with respective concentration were used: penicillin (1 unit 
Statistical analysis
Statistical analysis was done by SPSS version 20 statistical software. Participants' demographic and clinical characteristic were described by using descriptive statistics. Bivariate and multivariate logistic regression analysis were done to identify the clinical predictors for GAS pharyngitis and P-value less than 0.05 taken as statistically significant at 95% confidence level.
Ethical consideration
Ethical clearance was obtained from Jimma University Ethical Review Board. Prior to recruitment of study participants, letter of permission and written informed consent were secured from the health facility managements and the parents=caregivers= respectively. The purpose of the study was clearly described to the study participants and confidentiality was kept.
Results
Socio-demographic characteristics and prevalence of GAS
A total of, 355 children between ages of 5 and 15 years with pharyngitis were enrolled from May 8 to December 31, 2013. Females accounted for 57.7% and urban residents were 93.0%. Sixty-six percent of the children were 5-9 years old with mean ± SD age of 8.5 ± 2.7. Moreover, the average family size of the target population was 4.6 with mean of 1.8 children less than 15 years per household (Table 1) .
In this study, the overall prevalence of group A Streptococcus (GAS) was 11.3% (40=355). The prevalence of GAS in females was 11.7%, in children aged 10-15 years 14.2%, among rural residents 16% and in children with family income 625 USD=month 14.8% (Table 1) .
Sixty-three percent of children had an episode of sore throat of which 27 (12.1%) were culture positive for GAS. About 33.5% of study participant children experienced single episode of sore throat in the previous year of which 14.7% became culture positive for GAS. Similarly, 11.2% of the children had five times recurrent episodes of sore throat which 24% were culture positive for GAS ( Table 2 ).
Antimicrobial susceptibility pattern of GAS isolates
The antimicrobial drug susceptibility profile showed that all GAS isolates were susceptible to penicillin G, amoxicillin, erythromycin, clindamycin, chloramphenicol and ceftriaxone. However, more than 52% of those isolates were resistant to tetracycline.
Clinical predictors for GAS pharyngitis in children
The bivariate logistic regression analysis was done to identify clinical signs and symptom predictors for throat culture. .001] were found to be independent predictors for GAS pharyngitis in children (Table 3 ).
Discussion
Group A Streptococcus (GAS) is the most common bacterial cause of acute pharyngitis, responsible for 20-30% of sore throat in children. 15 The overall prevalence of 11.3% GAS detected in our study was comparable with 11% reported in Turkey, 16 12% in Brazil 17 and 9.7% among healthy school children in Ethiopia. 18 But, it was much higher than the prevalence of 2.8%, 4.1% and 7.9%, in India, 19 Taiwan 20 and Indonesia 21 respectively. On the other hand, the 11.3% prevalence of GAS in our study was much lower than 40.6% reported in Ethiopia. 6 This low prevalence of GAS in the current study may be due to a difference in seasons where the previous study in Ethiopia was conducted from February to May when the carriage rate and infection of GAS reached the maximum. Moreover, civil war during 1992 in Ethiopia may have contributed to an influx of people to the big cities causing crowding and lower standards of living which might be the reason for observed high prevalence of GAS in the former study. 6 In addition to this, the low prevalence rate in our study is probably due to the trends of over prescription of antibiotics in health facilities as it was demonstrated in our data where 100% of children with pharyngitis received either amoxicillin or penicillin. Such indiscriminate use of antibiotics might contribute for the low carriage rate of GAS in the community. Similarly, 11.3% prevalence of GAS in our study was lower than the findings in Egypt, 22 Tunisia, 23 Yemen, 24 Brazil 25 and USA 26 where average prevalence of 17-58% was reported. Such variation may be due to differences in methodology, seasons of sample collection and geographical variation of study settings.
In this study, all GAS isolates were susceptible to penicillin, amoxicillin, erythromycin, clindamycin, chloramphenicol and ceftriaxone, which go in agreement with previous studies in Ethiopia 6, 18 where no b-lactams and macrolides drug resistant was reported. These findings indicated that b-lactams and macrolides remain as the drug of choice for the treatment of GAS infection. It is known that erythromycin and clindamycin are usually used as an alternative treatment for patients allergic to penicillin. Fortunately in this study, no single isolate of GAS became resistant to erythromycin and clindamycin which was in agreement with findings elsewhere in Ethiopia, 6, 18 Egypt 22 and Brazil. 27 However, various levels of resistance to erythromycin and clindamycin were reported in Turkey, 16 Tunisia 28 and China. 29 In the present study, 52.5% GAS isolates were resistant to tetracycline which was comparable with 68% reported in Ethiopia 6 and 50% in Brazil, 27 but much lower than 70% and 94% resistance rates documented in Tunisia 28 and China 29 respectively.
According to multivariate logistic regression analysis, absence of cough, presence of tonsillar swelling or exudate and body temperature >38°(P < 0.05) were found to be independent predictors for GAS infection among children with pharyngitis. Similar findings were revealed in Canada, 30 USA [31] [32] [33] and Yemen. 24 However, it is important to know that the clinical variables that are predictor for GAS infection may vary with different GAS strains, geographic area and immunity profile of the study population. 22 
Conclusion
In this study the prevalence of GAS was relatively low. However, the seasonality of GAS infection might underestimate the prevalence, so that large-scale prospective study in the entire season and in various settings is required to understand the actual burden of infection. In our study, all GAS isolates remained susceptible to penicillins and macrolides indicating that those are still the drug of choice for the treatment of GAS infection in that locality. Furthermore, the clinical variables that are predictor of GAS pharyngitis can be considered for the diagnosis of GAS pharyngitis with further evaluation of its reproducibility in different settings.
